Frontier and Hotspot Evolution in Cardiorenal Syndrome: A Bibliometric Analysis From 2003 to 2022

Denic, 2016, Structural and functional changes with the aging kidney, Adv Chronic Kidney Dis, 23, 19, 10.1053/j.ackd.2015.08.004 Glassock, 2016, Aging and the kidneys: anatomy, physiology and consequences for defining chronic kidney disease, Nephron, 134, 25, 10.1159/000445450 Obas, 2018, The aging heart, Clin Sci, 132, 1367, 10.1042/CS20171156 Breidthardt, 2011, Effect and clinical prediction of worsening renal function in acute decompensated heart failure, Am J Cardiol, 107, 730, 10.1016/j.amjcard.2010.10.056 Bagshaw, 2010, Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference, Nephrol Dial Transplant, 25, 1406, 10.1093/ndt/gfq066 Gottlieb, 2002, The prognostic importance of different definitions of worsening renal function in congestive heart failure, J Card Fail, 8, 136, 10.1054/jcaf.2002.125289 Damman, 2009, Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH), Eur J Heart Fail, 11, 847, 10.1093/eurjhf/hfp108 McAlister, 2004, Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study, Circulation, 109, 1004, 10.1161/01.CIR.0000116764.53225.A9 Ezekowitz, 2004, The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease, J Am Coll Cardiol, 44, 1587, 10.1016/j.jacc.2004.06.072 McClellan, 2004, Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease, J Am Soc Nephrol, 15, 1912, 10.1097/01.ASN.0000129982.10611.4C Hillege, 2006, Renal function as a predictor of outcome in a broad spectrum of patients with heart failure, Circulation, 113, 671, 10.1161/CIRCULATIONAHA.105.580506 Uchino, 2005, Acute renal failure in critically ill patients: a multinational, multicenter study, J Am Med Assoc, 294, 813, 10.1001/jama.294.7.813 Chertow, 2005, Acute kidney injury, mortality, length of stay, and costs in hospitalized patients, J Am Soc Nephrol, 16, 3365, 10.1681/ASN.2004090740 2018, 1, S79 Urine, 1961, Renal disease, Lancet, 277, 821, 10.1016/S0140-6736(61)90136-2 Bock, 2010, Cardiorenal syndrome: new perspectives, Circulation, 121, 2592, 10.1161/CIRCULATIONAHA.109.886473 Schefold, 2016, Heart failure and kidney dysfunction: epidemiology, mechanisms and management, Nat Rev Nephrol, 12, 610, 10.1038/nrneph.2016.113 Hatamizadeh, 2013, Cardiorenal syndrome: pathophysiology and potential targets for clinical management, Nat Rev Nephrol, 9, 99, 10.1038/nrneph.2012.279 Zannad, 2018, Cardiorenal syndrome revisited, Circulation, 138, 929, 10.1161/CIRCULATIONAHA.117.028814 Damman, 2014, Terminology and definition of changes renal function in heart failure, Eur Heart J, 35, 1527 Chen, 2014, Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace, Expert Opin Biol Ther, 35, 3413 Yuan, 2012, Cardiac rehabilitation: a bibliometric review from 2001 to 2020, Front Cardiovasc Med, 12, 593 Chen, 2016 Chen, 2008, An information-theoretic view of visual analytics, IEEE Comput Graph Appl, 28 Chen, 2004, Searching for intellectual turning points: progressive knowledge domain visualization, Proc Natl Acad Sci U S A, 101 Chen, 2006, detecting and visualizing emerging trends and transient patterns in scientific literature, J Am Soc Inf Sci Technol, 57, 359, 10.1002/asi.20317 Wu, 2021, Bibliometric analysis of global research trends on ultrasound microbubble: a quickly developing field, Front Pharmacol, 12 Hu, 2015, An analysis of the evolution of topics and future trends in ecological security research, Shengtai Xuebao, 35, 6934 Bongartz, 2005, The severe cardiorenal syndrome: “Guyton revisited, Eur Heart J, 26, 11, 10.1093/eurheartj/ehi020 Ronco, 2008, Cardiorenal syndrome, J Am Coll Cardiol, 52, 1527, 10.1016/j.jacc.2008.07.051 Haase, 2013, Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the acute dialysis quality initiative (ADQI), Contrib Nephrol, 182, 99, 10.1159/000349969 Cruz, 2013, Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the acute dialysis quality initiative (ADQI), Contrib Nephrol, 182, 117, 10.1159/000349968 Braam, 2014, Cardiorenal syndrome-current understanding and future perspectives, Nat Rev Nephrol, 10, 48, 10.1038/nrneph.2013.250 Damman, 2015, The kidney in heart failure: an update, Eur Heart J, 36, 1437, 10.1093/eurheartj/ehv010 Smith, 2003, Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?, J Card Fail, 9, 13, 10.1054/jcaf.2003.3 Heywood, 2005, The cardiorenal syndrome: lessons from the ADHERE database andtreatment options, Heart Fail Rev, 9, 195, 10.1007/s10741-005-6129-4 Heywood, 2007, High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database, J Card Fail, 13, 422, 10.1016/j.cardfail.2007.03.011 Smith, 2006, Renal impairment and outcomes in heart failure. Systematic review and meta-analysis, J Am Coll Cardiol, 47, 1987, 10.1016/j.jacc.2005.11.084 Metra, 2008, Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance, Eur J Heart Fail, 10, 188, 10.1016/j.ejheart.2008.01.011 Damman, 2007, Worsening renal function and prognosis in heart failure: systematic review and meta-analysis, J Card Fail, 13, 599, 10.1016/j.cardfail.2007.04.008 Forman, 2004, Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure, J Am Coll Cardiol, 43, 61, 10.1016/j.jacc.2003.07.031 Cowie, 2006, Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: Results of the prospective outcomes study in heart failure (POSH), Eur Heart J, 27, 1216, 10.1093/eurheartj/ehi859 Damman, 2014, Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis, Eur Heart J, 35, 455, 10.1093/eurheartj/eht386 Butler, 2004, Relationship between heart failure treatment and development of worsening renal function among hospitalized patients, Am Heart J, 147, 331, 10.1016/j.ahj.2003.08.012 Blair, 2011, Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial, Eur Heart J, 32, 2563, 10.1093/eurheartj/ehr238 Metra, 2012, Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function, Circ Hear Fail, 5, 54, 10.1161/CIRCHEARTFAILURE.111.963413 Testani, 2010, Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure, Am J Cardiol, 106, 1763, 10.1016/j.amjcard.2010.07.050 Mishra, 2005, Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery, Lancet, 365, 1231, 10.1016/S0140-6736(05)74811-X Maisel, 2011, Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial, Eur J Heart Fail, 13, 846, 10.1093/eurjhf/hfr087 Aghel, 2010, Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure, J Card Fail, 16, 49, 10.1016/j.cardfail.2009.07.003 Damman, 2008, Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure, Eur J Heart Fail, 10, 997, 10.1016/j.ejheart.2008.07.001 Lassus, 2010, Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome, Eur Heart J, 31, 2791, 10.1093/eurheartj/ehq293 Damman, 2013, Tubular damage and worsening renal function in chronic heart failure, JACC Hear Fail, 1, 417, 10.1016/j.jchf.2013.05.007 Ahmad, 2018, Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury, Circulation, 137, 2016, 10.1161/CIRCULATIONAHA.117.030112 Nohria, 2008, Cardiorenal interactions. Insights from the ESCAPE trial, J Am Coll Cardiol, 51, 1268, 10.1016/j.jacc.2007.08.072 Hanberg, 2016, Reduced cardiac index is not the dominant driver of renal dysfunction in heart failure, J Am Coll Cardiol, 67, 2199, 10.1016/j.jacc.2016.02.058 Damman, 2009, Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease, J Am Coll Cardiol, 53, 582, 10.1016/j.jacc.2008.08.080 Mullens, 2008, Elevated intra-abdominal pressure in acute decompensated heart failure. A potential contributor to worsening renal function?, J Am Coll Cardiol, 51, 300, 10.1016/j.jacc.2007.09.043 Faul, 2011, FGF23 induces left ventricular hypertrophy, J Clin Invest, 121, 4393, 10.1172/JCI46122 Cho, 2013, Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model, Nephrol Dial Transplant, 28, 2766, 10.1093/ndt/gft376 Engeln, 2011, Diuretic strategies in patients with acute decompensated heart failure, J Emerg Med, 364, 797 Damman, 2011, Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function, J Am Coll Cardiol, 57, 2233, 10.1016/j.jacc.2010.10.065 Costanzo, 2007, Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure, J Am Coll Cardiol, 49, 675, 10.1016/j.jacc.2006.07.073 Bart, 2012, Ultrafiltration in decompensated heart failure with cardiorenal syndrome, N Engl J Med, 367, 2296, 10.1056/NEJMoa1210357 Gheorghiade, 2007, Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials, J Am Med Assoc, 297, 1332, 10.1001/jama.297.12.1332 Konstam, 2007, Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial, J Am Med Assoc, 297, 1319, 10.1001/jama.297.12.1319 Verbrugge, 2013, Abdominal contributions to cardiorenal dysfunction in congestive heart failure, J Am Coll Cardiol, 62, 485, 10.1016/j.jacc.2013.04.070 Costanzo, 2016, Aquapheresis versus intravenous diuretics and hospitalizations for heart failure, JACC Hear Fail, 4, 95, 10.1016/j.jchf.2015.08.005 McMurray, 2014, Angiotensin-neprilysin inhibition versus enalapril in heart failure, N Engl J Med, 371, 993, 10.1056/NEJMoa1409077 Steiner, 2016, Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes, Zeitschrift fur Gefassmedizin, 374, 1092 Guthrie, 2018, Canagliflozin and cardiovascular and renal events in type 2 diabetes, Postgrad Med, 130, 149, 10.1080/00325481.2018.1423852 Colombo, 2019, Dapagliflozin in patients with heart failure and reduced ejection fraction, Intern Emerg Med, 381, 1995 Ronco, 2018, Cardiorenal syndrome: an overview, Adv Chronic Kidney Dis, 25, 382, 10.1053/j.ackd.2018.08.004 Rangaswami, 2019, Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association, Circulation, 139, e840